[HTML][HTML] Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a …
H Iwase, Y Yamamoto, M Yamamoto-Ibusuki… - British journal of …, 2013 - nature.com
Background: Oestrogens usually stimulate the progression of oestrogen receptor (ER)-
positive breast cancer. Paradoxically, high-dose oestrogens suppress the growth of these
tumours in certain circumstances. Methods: We prospectively examined the efficacy and
safety of ethinylestradiol treatment (3 mg per day oral) in postmenopausal patients with
advanced or recurrent ER-positive breast cancer who had previously received endocrine
therapies, especially those with resistance to aromatase inhibitors. Results: Eighteen …
positive breast cancer. Paradoxically, high-dose oestrogens suppress the growth of these
tumours in certain circumstances. Methods: We prospectively examined the efficacy and
safety of ethinylestradiol treatment (3 mg per day oral) in postmenopausal patients with
advanced or recurrent ER-positive breast cancer who had previously received endocrine
therapies, especially those with resistance to aromatase inhibitors. Results: Eighteen …
[引用][C] Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a …
WR Gwin, PK Marcom - Breast Diseases: A Year Book Quarterly, 2014 - infona.pl
Iwase H, Yamamoto Y, Yamamoto-Ibusuki M, et al (Kumamoto Univ, Chuo-ku, Japan; et al)
Br J Cancer 109:1537-1542, 2013§ … Ethinylestradiol is beneficial for postmenopausal
patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor
treatment: a prospective study Iwase H, Yamamoto Y, Yamamoto-Ibusuki M, et al (Kumamoto
Univ, Chuo-ku, Japan; et al) Br J Cancer 109:1537-1542, 2013§ …
Br J Cancer 109:1537-1542, 2013§ … Ethinylestradiol is beneficial for postmenopausal
patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor
treatment: a prospective study Iwase H, Yamamoto Y, Yamamoto-Ibusuki M, et al (Kumamoto
Univ, Chuo-ku, Japan; et al) Br J Cancer 109:1537-1542, 2013§ …
以上显示的是最相近的搜索结果。 查看全部搜索结果